Company / Current Assets per Share
Haemonetics Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$18.41
FY2025
5-year range
$13.51 / $18.41
FY2021-FY2025
Trend
+20.8%
vs FY2024
Sector context
#62 of 163
Health Care
What the data says
At $18.41, Haemonetics's current assets per share ranks #62 of 163 in the Health Care sector. Current Assets per Share has increased for 7 consecutive years, from $9.97 in FY2018 to $18.41 in FY2025.
Based on SEC 10-K filings.
18.41 in FY2025 with a 5-year CAGR of +9.4%.
Improved from $14.98 to $18.41 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
#62 of 163 in Health CareTop 38% of 163This company $18.41 Sector average $52.74
▼
-65.1% below sector average
Key checks
Key Insights
- Haemonetics's current assets per share has grown for 7 consecutive years.
- In FY2025, current assets per share increased 20.8% year-over-year.
- Ranks #62 out of 163 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.41 | +20.8% |
| FY2024 | $15.24 | +1.8% |
| FY2023 | $14.98 | +1.9% |
| FY2022 | $14.70 | +8.9% |
| FY2021 | $13.51 | +14.8% |
| FY2020 | $11.77 | +5.8% |
| FY2019 | $11.12 | +11.5% |
| FY2018 | $9.97 | -0.4% |
| FY2017 | $10.01 | +6.0% |
| FY2016 | $9.45 | -11.9% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026